If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApplied Nutrition PLC Regulatory News (APN)

Share Price Information for Applied Nutrition PLC (APN)

Share Price is delayed by 15 minutes
Get Live Data
315.50    0.50 (0.16%)
Bid:
314.50
Ask:
316.00
Spread: 1.50 (0.477%)
Market Cap: £788.75m
APN Live PriceLast checked at - London Stock Exchange

Intraday Applied Nutrition PLC Share Chart

Trading Update

9 Dec 2025 07:00

RNS Number : 7156K
Applied Nutrition PLC
09 December 2025
 

9 December 2025 

 Applied Nutrition plc

 

(the "Company")

Trading Update

 

Applied Nutrition plc (LSE: APN), a leading sports nutrition, health and wellness brand, today announces an update on trading for the current financial year ending 31 July 2026 ("FY26").

 

Further to the Company's positive trading outlook mentioned in the Final Results announcement on 10 November 2025, Applied Nutrition is pleased to announce that the strong momentum has continued and is also reflected in the current order book.

 

As a result the Company now expects that FY26 results are likely to exceed current market consensus estimates1 by approximately 10%.

 

The Company recognises the strength of trading and the upcoming peak trading period for Health, Fitness & Wellbeing, which will deliver a particularly strong H1.

 

 

Consensus market expectations for FY26 before today were revenue of £122.3m and adjusted EBITDA of £34.4m.

For further information please contact:

Applied Nutrition plc Thomas Ryder, Chief Executive OfficerSteven Granite, Chief Operating OfficerJoe Pollard, Chief Financial Officer

Via Alma

Alma Strategic Communications (Public Relations adviser to Applied Nutrition plc)

Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters

+44 (0) 203 405 0205

appliednutrition@almastrategic.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Applied Nutrition is Joe Pollard, Chief Financial Officer.

Notes to editors

Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products with a stated aim of being the world's most trusted and innovative brand in the market.

Headquartered in the UK, the Group sells products in over 85 countries worldwide and has a diverse product range, targeting elite athletes, gym goers and health-conscious consumers. Applied Nutrition has developed and launched four ranges under the umbrella of the Applied Nutrition brand - Applied Nutrition, ABE, BodyFuel, and Endurance. Across the four ranges, the Group sells over 100 different products.

Applied Nutrition's growth is fuelled by a market-leading product portfolio, created and largely manufactured in-house at its Knowsley, Liverpool headquarters by a team of industry experts. This end-to-end capability allows the Group to innovate at speed, refresh and enhance existing products and introduce new offerings that anticipate and respond to the latest consumer trends.

Applied Nutrition largely operates a global business-to-business (B2B) model, which has facilitated a low risk, highly cost-effective go-to-market strategy and has enabled strong, profitable growth in the UK, Europe and other international geographies. The business model and strategy has enabled the Group to become a fast-growing, highly profitable and cash generative global supplier in the sports nutrition, health and wellness market.

For further information, please visit www.appliednutritionplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWRBRVVUURAA
Date   Source Headline
15th Aug 20071:34 pmRNSAIM Rule 26
9th Aug 200710:35 amRNSHolding(s) in Company
16th Jul 20077:00 amRNSChange of Adviser
25th Jun 20077:02 amRNSInterim Results
11th Jun 200711:38 amPRNIssue of Equity
19th Apr 20077:01 amRNSTrading Update
12th Mar 20072:47 pmPRNHolding(s) in Company
7th Mar 20072:25 pmPRNHolding(s) in Company
26th Feb 20077:04 amRNSFurther Orders
23rd Feb 20077:00 amPRNHolding(s) in Company
23rd Feb 20077:00 amPRNHolding(s) in Company
29th Jan 20077:01 amRNSAGM Statement
17th Jan 20073:51 pmPRNHolding(s) in Company
9th Jan 200712:22 pmPRNHolding(s) in Company
5th Jan 20077:53 amRNSNew Orders
22nd Dec 20069:32 amRNSDirectorate Change
19th Dec 200610:07 amPRNIssue of Equity
13th Dec 20064:38 pmPRNTotal Voting Rights
11th Dec 20067:01 amRNSFinal Results
10th Oct 20067:01 amRNSTrading Statement
5th Oct 20064:09 pmPRNHolding(s) in Company
3rd Aug 20062:58 pmPRNHolding(s) in Company
1st Aug 20067:02 amRNSHolding(s) in Company
28th Jul 200612:36 pmRNSHolding(s) in Company
20th Jul 200612:45 pmRNSAcquires Genesis UK
4th Jul 200612:08 pmRNSNew Contract
19th Jun 20067:00 amRNSInterim Results
26th May 20062:02 pmRNSRe Contract
10th May 200611:08 amRNSRe Contract
2nd May 200611:36 amRNSAGM Statement
13th Apr 20067:01 amRNSTrading Statement
13th Mar 20067:00 amRNSNew Contract
8th Mar 20067:02 amRNSMajor New Contract
3rd Feb 20067:00 amRNSNew Orders
2nd Feb 20067:00 amPRNHolding(s) in Company
5th Jan 20064:58 pmPRNHolding(s) in Company
4th Jan 200610:11 amPRNCorrection: Admission to AIM
4th Jan 20067:00 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.